{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:07:09Z","timestamp":1780567629783,"version":"3.54.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0108273","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T17:53:43Z","timestamp":1412186023000},"page":"e108273","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prevention of Immune Nephritis by the Small Molecular Weight Immunomodulator Iguratimod in MRL\/lpr Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Qingran","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunde","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Du F, L\u00fc L-j, Fu Q, Dai M, Teng J-l, et al.. (2008) T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis. Arthritis research & therapy 10.","DOI":"10.1186\/ar2554"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.intimp.2012.03.003","article-title":"T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro","volume":"13","author":"F Du","year":"2012","journal-title":"International Immunopharmacology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00029330-200804010-00008","article-title":"Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial","volume":"121","author":"LJTJ L\u00fc","year":"2008","journal-title":"Chin Med J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/art.24643","article-title":"Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate","volume":"61","author":"LJ Lu","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/s10165-006-0542-y","article-title":"Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study","volume":"17","author":"M Hara","year":"2007","journal-title":"Modern rheumatology\/the Japan Rheumatism Association"},{"key":"ref6","first-page":"2591","article-title":"Inhibitory effect of T-614 on tumor necrosis factor-alpha induced cytokine production and nuclear factor-kappaB activation in cultured human synovial cells","volume":"28","author":"M Kohno","year":"2001","journal-title":"The Journal of rheumatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.1300832","article-title":"A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide","volume":"191","author":"Q Luo","year":"2013","journal-title":"The Journal of Immunology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0162-3109(00)00242-3","article-title":"Inhibition of L-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug, T614","volume":"49","author":"T Sawada","year":"2000","journal-title":"Immunopharmacology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/rheumatology\/keg381","article-title":"Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice","volume":"42","author":"K Tanaka","year":"2003","journal-title":"Rheumatology (Oxford, England)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nrrheum.2010.68","article-title":"B cells as therapeutic targets in SLE","volume":"6","author":"I Sanz","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Zhou X, Cheng F, Zhang H (2014) Emerging View of Autophagy in Systemic Lupus Erythematosus. International Reviews of Immunology 0: null.","DOI":"10.3109\/08830185.2013.879711"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4049\/jimmunol.163.3.1682","article-title":"Abnormal NF-\u03baB Activity in T Lymphocytes from Patients with Systemic Lupus Erythematosus Is Associated with Decreased p65-RelA Protein Expression","volume":"163","author":"HK Wong","year":"1999","journal-title":"The Journal of Immunology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.05.004","article-title":"Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus","volume":"154","author":"JC Martin","year":"2014","journal-title":"Clinical Immunology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.176.6.1645","article-title":"Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci","volume":"176","author":"ML Watson","year":"1992","journal-title":"The Journal of Experimental Medicine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.iy.09.040191.001331","article-title":"Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease","volume":"9","author":"P Cohen","year":"1991","journal-title":"Annual review of immunology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM197210262871701","article-title":"Metabolism of Third Complement Component (C3) in Nephritis","volume":"287","author":"LG Hunsicker","year":"1972","journal-title":"New England Journal of Medicine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/intimm\/dxl047","article-title":"Spontaneous B cell hyperactivity in autoimmune-prone MRL mice","volume":"18","author":"A Nijnik","year":"2006","journal-title":"International immunology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.4049\/jimmunol.149.9.3097","article-title":"Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr","volume":"149","author":"T Giese","year":"1992","journal-title":"The Journal of Immunology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.129.6.2612","article-title":"Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset","volume":"129","author":"HC Morse","year":"1982","journal-title":"The Journal of Immunology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0090-1229(84)90006-0","article-title":"Cyclophosphamide-induced changes in the MRL-lprlpr mouse: Effects upon cellular composition, immune function, and disease","volume":"30","author":"HR Smith","year":"1984","journal-title":"Clinical immunology and immunopathology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrrheum.2010.64","article-title":"Cytokines as therapeutic targets in SLE","volume":"6","author":"L Ronnblom","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-09-110874","article-title":"TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts","volume":"111","author":"C Bossen","year":"2008","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood.V85.2.487.487","article-title":"Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis","volume":"85","author":"M Kawano","year":"1995","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/s10165-006-0543-x","article-title":"Long-term safety study of iguratimod in patients with rheumatoid arthritis","volume":"17","author":"M Hara","year":"2007","journal-title":"Modern rheumatology\/the Japan Rheumatism Association"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"S Reagan-Shaw","year":"2008","journal-title":"The FASEB Journal"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"G Tsokos","year":"2011","journal-title":"The New England journal of medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0165-5728(98)00056-3","article-title":"A new anti-rheumatic drug, T-614, effectively suppresses the development of autoimmune encephalomyelitis","volume":"89","author":"Y Aikawa","year":"1998","journal-title":"Journal of neuroimmunology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.20147","article-title":"Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide","volume":"50","author":"G Cunnane","year":"2004","journal-title":"Arthritis & Rheumatism"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3899\/jrheum.090450","article-title":"Serum BLC\/CXCL13 Concentrations and Renal Expression of CXCL13\/CXCR5 in Patients with Systemic Lupus Erythematosus and Lupus Nephritis","volume":"37","author":"H-T Lee","year":"2010","journal-title":"The Journal of rheumatology"},{"key":"ref30","first-page":"9","article-title":"The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression","volume":"2013","author":"C-Y Sun","year":"2013","journal-title":"International Journal of Rheumatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.171.1.489","article-title":"Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB\/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition","volume":"171","author":"L Schiffer","year":"2003","journal-title":"The Journal of Immunology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1681\/ASN.2010050515","article-title":"Local Renal Autoantibody Production in Lupus Nephritis","volume":"22","author":"M Espeli","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e58140","DOI":"10.1371\/journal.pone.0058140","article-title":"Early differentiated CD138(high) MHCII+ IgG+ plasma cells express CXCR3 and localize into inflamed kidneys of lupus mice","volume":"8","author":"S Lacotte","year":"2013","journal-title":"PLoS ONE"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.4049\/jimmunol.1003871","article-title":"IL-21 Receptor Is Required for the Systemic Accumulation of Activated B and T Lymphocytes in MRL\/MpJ-Faslpr\/lpr\/J Mice","volume":"188","author":"AL Rankin","year":"2012","journal-title":"The Journal of Immunology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/eji.1830200124","article-title":"In vivo cytokine gene expression in T cell subsets of the autoimmune MRL\/Mp-lpr\/lpr mouse","volume":"20","author":"LJ Murray","year":"1990","journal-title":"European Journal of Immunology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.4049\/jimmunol.1001931","article-title":"B Cell Maturation Antigen Deficiency Exacerbates Lymphoproliferation and Autoimmunity in Murine Lupus","volume":"186","author":"C Jiang","year":"2011","journal-title":"The Journal of Immunology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.4049\/jimmunol.0903595","article-title":"Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL\/6\u2013lpr\/lpr Mice","volume":"184","author":"VC Kyttaris","year":"2010","journal-title":"The Journal of Immunology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0108273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T23:44:12Z","timestamp":1689551052000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0108273"}},"subtitle":[],"editor":[{"given":"Jean","family":"Kanellopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0108273","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}